Logo-jpe
Submitted: 27 Oct 2022
Accepted: 26 Jul 2023
ePublished: 05 Aug 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Prev Epidemiol. 2023;8(2): e34192.
doi: 10.34172/jpe.2023.34192
  Abstract View: 302
  PDF Download: 228

Review

Possibility of the blood clot, thrombotic thrombocytopenia following injection of COVID-19-vaccine AstraZeneca; a systematic review

Mahnaz Momenzadeh 1 ORCID logo, Ebrahim Moayedi 2 ORCID logo, Seyedeh Leila Dehghani 3, Shahrzad Shadabi 4, Mohammad Moein Derakhshan Barjoei 5, Masoumeh Sadat Mousavi 2,6* ORCID logo, Samira Pourrezaei 7

1 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Epidemiology and Biostatistics, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Department of Public Health Behbahan Faculty of Medical Sciences, Behbahan, Iran
4 Graduated in Medical Virology University of Kerman, Kerman, Iran
5 Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
6 Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
7 Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Masoumeh Sadat Mousavi, Email: mousavi68.ma@yahoo. com, , Email: ma@skums.ac.ir

Abstract

Introduction: Recently, it has been reported that the injection of vaccines such as the ChAdOx1 nCoV-19 (AstraZeneca) involves some rare cases of thrombocytopenia and blood clots, although the vaccines created immunity in people. Estimates of this phenomenon are not the same in different countries, probably due to age distribution and number.

Objectives: This study attempted to study AstraZeneca’s rare side effects in people injected with this vaccine.

Methods: This systematic study was conducted using articles published in 2021 under the title of blood clot and thrombocytopenia by AstraZeneca injection. The references and data were gathered through national and international sites such as Magiran, Google Scholar, PubMed, Web of Science, and Scopus. They were also gathered and examined using report cases and the available data on COVID-19 vaccine immunization in various countries. The keywords used mainly are COVID-19 vaccine, ChAdOx1 nCoV-19 vaccine, blood clots, thrombus, thrombotic, and thrombocytopenia. Eventually, 25 articles were searched and examined, of which 15 related ones were selected after reviewing and re-studying. While investigating the summary and method in those 15, they were filtered more accurately; finally, ten articles were chosen. Inclusion criteria consisted of all related articles and exclusion criteria contained articles that were less related to our research subject after purification or were redundant and not of high quality.

Results: This study found that rare blood clot cases and thrombocytopenia were seen despite mild side effects after AstraZeneca injection. After assessing its benefits, adverse effects, and age distribution, the countries using AstraZeneca decided to continue using it. The main difference in reported statistics in these countries is due to the variety in the age and number of people receiving the vaccine.

Conclusion: Blood clots and thrombocytopenia are among the rare side effects of the AstraZeneca vaccine. In different countries, the vaccine side effects vary depending on the age and number of participants. Anyway, according to the investigations conducted in this area, the highest records of these side effects are observed in Norway, which is still low. Overall, through studying this study and other similar ones, politicians, managers, and even ordinary people can be informed about the pros and cons of this vaccine.


Citation: Momenzadeh M, Moayedi E, Dehghani SL, Shadabi S, Derakhshan Barjoei MM, Mousavi MS, Pourrezaei S. Possibility of the blood clot, thrombotic thrombocytopenia following injection of COVID-19-vaccine AstraZeneca; a systematic review. J Prev Epidemiol. 2023;8(2):e34192. doi: 10.34172/ jpe.2023.34192.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 303

Your browser does not support the canvas element.


PDF Download: 228

Your browser does not support the canvas element.